PT1692105E - Processo para a preparação de derivados de (3-oxo-2,3-di-hidro-1h-isoindol-1-il)-acetilguanidina - Google Patents

Processo para a preparação de derivados de (3-oxo-2,3-di-hidro-1h-isoindol-1-il)-acetilguanidina Download PDF

Info

Publication number
PT1692105E
PT1692105E PT04803188T PT04803188T PT1692105E PT 1692105 E PT1692105 E PT 1692105E PT 04803188 T PT04803188 T PT 04803188T PT 04803188 T PT04803188 T PT 04803188T PT 1692105 E PT1692105 E PT 1692105E
Authority
PT
Portugal
Prior art keywords
isoindol
dihydro
oxo
producing
acetylguanidine
Prior art date
Application number
PT04803188T
Other languages
English (en)
Inventor
Heinz-Werner Kleemann
Gerrit Schubert
Joerg Rieke-Zapp
Johannes Keil
Reda Hanna
Bao-Guo Huang
Xiao-Dong Wu
Yves Gouraud
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of PT1692105E publication Critical patent/PT1692105E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
PT04803188T 2003-12-02 2004-11-19 Processo para a preparação de derivados de (3-oxo-2,3-di-hidro-1h-isoindol-1-il)-acetilguanidina PT1692105E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10356717A DE10356717A1 (de) 2003-12-02 2003-12-02 Verfahren zur Herstellung von (3-Oxo-2,3-dihydro-1H-isoindol-1-yl)-acetylguanidin-Derivaten

Publications (1)

Publication Number Publication Date
PT1692105E true PT1692105E (pt) 2008-07-04

Family

ID=34638338

Family Applications (1)

Application Number Title Priority Date Filing Date
PT04803188T PT1692105E (pt) 2003-12-02 2004-11-19 Processo para a preparação de derivados de (3-oxo-2,3-di-hidro-1h-isoindol-1-il)-acetilguanidina

Country Status (38)

Country Link
EP (1) EP1692105B1 (pt)
JP (1) JP4809774B2 (pt)
KR (1) KR101202604B1 (pt)
CN (1) CN100526297C (pt)
AR (1) AR046733A1 (pt)
AT (1) ATE395334T1 (pt)
AU (1) AU2004295056B2 (pt)
BR (1) BRPI0417147A (pt)
CA (1) CA2548020C (pt)
CR (1) CR8376A (pt)
CY (1) CY1108187T1 (pt)
DE (2) DE10356717A1 (pt)
DK (1) DK1692105T3 (pt)
EC (1) ECSP066597A (pt)
EG (1) EG25498A (pt)
ES (1) ES2304634T3 (pt)
HK (1) HK1097525A1 (pt)
HR (1) HRP20080253T3 (pt)
IL (1) IL175834A (pt)
JO (1) JO2498B1 (pt)
MA (1) MA28220A1 (pt)
MY (1) MY136467A (pt)
NO (1) NO20063058L (pt)
NZ (1) NZ547625A (pt)
OA (1) OA13293A (pt)
PA (1) PA8618701A1 (pt)
PE (1) PE20051037A1 (pt)
PL (1) PL1692105T3 (pt)
PT (1) PT1692105E (pt)
RS (1) RS50571B (pt)
RU (1) RU2397159C2 (pt)
SI (1) SI1692105T1 (pt)
TN (1) TNSN06167A1 (pt)
TW (1) TWI334348B (pt)
UA (1) UA83883C2 (pt)
UY (1) UY28648A1 (pt)
WO (1) WO2005054195A1 (pt)
ZA (1) ZA200603338B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200812962A (en) * 2006-07-12 2008-03-16 Astrazeneca Ab New compounds I/418
CN102007138B (zh) * 2008-04-16 2014-05-21 橘生药品工业株式会社 吡唑衍生物的半富马酸盐
RU2518740C1 (ru) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ДИГИДРОХЛОРИД 2-(3,4-МЕТИЛЕНДИОКСИФЕНИЛ)-9-МОРФОЛИНОЭТИЛИМИДАЗО[1,2-a]БЕНЗИМИДАЗОЛА
CN107778238B (zh) * 2016-08-29 2022-07-22 中山大学 一种3，4-二氢异喹啉-1-酮的合成新方法
CN107286074B (zh) * 2017-08-16 2019-08-20 厦门华厦学院 3-羟基异吲哚-1-酮衍生物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946842A (en) * 1985-07-05 1990-08-07 Smith Kline & French Laboratories Limited Novel guanidino pyridazinones as cardiac stimulants
DE19737224A1 (de) * 1997-08-27 1999-03-18 Hoechst Marion Roussel De Gmbh Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen
DE19832429A1 (de) * 1998-07-18 2000-01-20 Hoechst Marion Roussel De Gmbh Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP1385823B1 (en) * 2001-04-09 2006-12-13 Chiron Corporation Guanidino compounds as melanocortin-4 receptor (mc4-r) agonists
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant

Also Published As

Publication number Publication date
CA2548020C (en) 2013-01-08
IL175834A (en) 2010-12-30
UY28648A1 (es) 2005-06-30
MA28220A1 (fr) 2006-10-02
OA13293A (en) 2007-01-31
RS50571B (sr) 2010-05-07
CR8376A (es) 2007-12-04
NZ547625A (en) 2010-01-29
PL1692105T3 (pl) 2008-09-30
TW200526207A (en) 2005-08-16
RU2397159C2 (ru) 2010-08-20
KR101202604B1 (ko) 2012-11-19
ECSP066597A (es) 2006-10-25
ATE395334T1 (de) 2008-05-15
DE10356717A1 (de) 2005-07-07
CA2548020A1 (en) 2005-06-16
AU2004295056A1 (en) 2005-06-16
EP1692105B1 (de) 2008-05-14
JP4809774B2 (ja) 2011-11-09
IL175834A0 (en) 2006-10-05
ES2304634T3 (es) 2008-10-16
TWI334348B (en) 2010-12-11
WO2005054195A1 (de) 2005-06-16
DK1692105T3 (da) 2008-08-25
RU2006123410A (ru) 2008-01-10
JO2498B1 (en) 2009-10-05
EG25498A (en) 2012-01-22
PA8618701A1 (es) 2006-07-03
KR20060111558A (ko) 2006-10-27
AR046733A1 (es) 2005-12-21
CN1886374A (zh) 2006-12-27
AU2004295056B2 (en) 2011-04-14
HK1097525A1 (en) 2007-06-29
ZA200603338B (en) 2007-06-27
JP2007516243A (ja) 2007-06-21
MY136467A (en) 2008-10-31
PE20051037A1 (es) 2005-12-29
DE502004007177D1 (de) 2008-06-26
NO20063058L (no) 2006-06-30
HRP20080253T3 (en) 2008-09-30
CN100526297C (zh) 2009-08-12
EP1692105A1 (de) 2006-08-23
BRPI0417147A (pt) 2007-03-06
CY1108187T1 (el) 2014-02-12
TNSN06167A1 (en) 2007-11-15
SI1692105T1 (sl) 2008-08-31
UA83883C2 (en) 2008-08-26

Similar Documents

Publication Publication Date Title
IL174029A0 (en) Process for preparing 2-oxo-1-pyrrolidine derivatives
IL178233A0 (en) Process for producing 5-hydroxy-4-thiomethylpyrazole derivatives
IL179107A0 (en) Method for preparing n-piperidino-1,5-diphenylpyrazole-3-carboxamide derivatives
PL1697390T3 (pl) Sposób wytwarzania organoacylofosforynów
EP1437326A4 (en) PROCESS FOR THE PREPARATION OF Si
HK1097525A1 (en) Method for producing (3-oxo-2,3-dihydro-1h-isoindol-1-yl) acetylguanidine derivatives
PL1641731T3 (pl) Sposób wytwarzania 1-oktenu z produktu CRACK-C4
EP1688422A4 (en) PROCESS FOR PREPARING AN ORGANOSILANE
EP1780192A4 (en) PROCESS FOR PREPARING A DIBROMFLUORBENZOLE DERIVATIVE
AU2003206964A8 (en) Method for producing riboflavin
EP1743902A4 (en) METHOD OF PREPARING A 5-ALPHA PRIMING DERIVATIVE
ZA200406665B (en) Method for producing toluol derivatives
IL166374A0 (en) Novel process for producing imidazoÄ1,2-bÜpyridazine derivative
HK1133870A1 (en) Method for producing 4-pentafluoride-sulfanyl-benzoylguanidines
EP1666474A4 (en) PROCESS FOR PRODUCTION OF PROPYLENEOXIDE
EP1556396A4 (en) METHOD OF PRODUCING 2-DESOXY-L-RIBOSE
HU0301605D0 (en) Method for producing hihg-purity citalopram
AU2003257058A1 (en) Method for making alkyhalosilanes
GB0421452D0 (en) Process for producing heterocyclic aldehyde
AU2003223951A1 (en) Method for producing substituted oxazoles
AU2003238603A1 (en) Method, instrument and apparatus for bowls production
SI1603868T1 (sl) Postopek za proizvodnjo alfa-(3-ariltio)-acetofenonov
SI1480963T1 (sl) Postopek za pripravo derivatov 3-amidinofenilalanina
HU0300941D0 (en) Method for producing dialkyl-3-oxo-glutarates
SI1685097T1 (sl) Postopek za pripravo 4-pentafluorid-sulfanil-benzoilgvanidinov